Haloperido en es it fr

Haloperido Brand names, Haloperido Analogs

Haloperido Brand Names Mixture

  • No information avaliable

Haloperido Chemical_Formula


Haloperido RX_link


Haloperido fda sheet

Haloperido FDA

Haloperido msds (material safety sheet)

Haloperido MSDS

Haloperido Synthesis Reference

P. A. J. Janssen, Belg. pat. 577,977 (1959), C.A. 54, 4630c (1960); idem, Brit. pat. 895,309 corresp to U.S. pat. 3,438,991 (1962, 1969 to Janssen).

Haloperido Molecular Weight

375.864 g/mol

Haloperido Melting Point

151.5 oC

Haloperido H2O Solubility

14 mg/L

Haloperido State


Haloperido LogP


Haloperido Dosage Forms

Injection; Oral solution; Tablet

Haloperido Indication

For the treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy also used in Tourette's syndrome and Severe hyperactivity.

Haloperido Pharmacology

Haloperidol is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Haloperidol has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Haloperidol has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.

Haloperido Absorption


Haloperido side effects and Toxicity

LD50=165 mg/kg (rats, oral)

Haloperido Patient Information


Haloperido Organisms Affected

Humans and other mammals